Publications
Detailed Information
Efficacy of oral alendronate in children with osteogenesis imperfecta
Cited 21 time in
Web of Science
Cited 26 time in Scopus
- Authors
- Issue Date
- 2005-09
- Publisher
- Lippincott Williams & Wilkins Ltd.
- Citation
- Journal of Pediatric Orthopaedics, Vol.25 No.5, pp.607-612
- Abstract
- The purpose of this study was to investigate the efficacy of oral alendronate for children with osteogenesis imperfecta. Nine boys and seven girls of average age 9.5 years were given oral alendronate for an average of 4 years. Fracture frequency decreased, and in more than half of the patients the ambulatory/mobility status improved. Bone mineral density improved significantly, and restoration of collapsed vertebral bodies was observed. Urinary excretion of calcium and a bone resorption marker decreased significantly. Iliac crest physis biopsy showed an expanded primary spongiosa area with numerous multinucleated cells. This study reveals that oral alendronate caused biochemical, radiologic, and histologic changes along with clinical improvement. Oral alendronate treatment, which is convenient for the school-age group, was found to be a tolerable and efficacious treatment for children with moderate or severe osteogenesis imperfecta.
- ISSN
- 0271-6798
- Files in This Item:
- There are no files associated with this item.
- Appears in Collections:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.